Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
39.33
0.00 (0.00%)
At close: May 6, 2026
Market Cap4.26B +22.7%
Revenue (ttm)448.33M +4.6%
Net Income23.54M -62.0%
EPS0.21 -62.9%
Shares Out108.29M
PE Ratio184.37
Forward PEn/a
Dividend0.05 (0.13%)
Ex-Dividend DateMay 20, 2025
Volume4,690,438
Average Volume4,351,037
Open37.71
Previous Closen/a
Day's Range37.53 - 39.44
52-Week Range25.87 - 53.99
Beta-0.06
RSI51.99
Earnings DateApr 16, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofe... [Read more]

Sector Healthcare
Founded 2004
Employees 696
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2025, SHE:301281's revenue was 398.23 million, a decrease of -14.12% compared to the previous year's 463.72 million. Earnings were 16.55 million, a decrease of -72.62%.

Financial Statements